Publications by authors named "Pierre Rudolph"

Claim this Profile
I
Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Christian Cordes, Ann-Kristin Münzel, Pierre Rudolph, Markus Hoffmann, Ivo Leuschner

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer.
Jan Bernd Weise, Pierre Rudolph, Axel Heiser, Marie-Luise Kruse, Jürgen Hedderich

Eur J Cancer· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids.
Tibor Görögh, Pierre Rudolph, Jens Eduard Meyer, Jochen A Werner, Burkard M Lippert

Clin Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy.
Christiane Kuropkat, Pierre Rudolph, Reza Parwaresch, Jochen A Werner

Anticancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis.
Matthias Krams, Reza Parwaresch, Bence Sipos, Klaus Heidorn, Dieter Harms, Pierre Rudolph

Oncogene· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.
Pierre Rudolph, Heidi Kühling, Per Alm, Mårten Fernö, Bo Baldetorp

Int J Cancer· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repp86 expression and outcome in patients with neuroblastoma.
Matthias Krams, Hans-Juergen Heidebrecht, Barbara Hero, Frank Berthold, Dieter Harms, Pierre Rudolph

J Clin Oncol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
Heidi Kühling, Per Alm, Håkan Olsson, Mårten Fernö, Bo Baldetorp, Pierre Rudolph

J Pathol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular storiform collagenoma.
Pierre Rudolph, Christoph Schubert, Reza Parwaresch

Am J Dermatopathol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
Matthias Krams, Barbara Hero, Frank Berthold, Reza Parwaresch, Dieter Harms, Pierre Rudolph

Am J Pathol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
repp86: A human protein associated in the progression of mitosis.
Hans-Juergen Heidebrecht, Sabine Adam-Klages, Monika Szczepanowski, Marc Pollmann, Friedrich Buck, Pierre Rudolph

Mol Cancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
Pierre Rudolph, Anna Maria Chiaravalli, Ursula Pauser, Ilske Oschlies, Marija Hillemanns

Virchows Arch· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Culprit and victim -- DNA topoisomerase II.
Udo Kellner, Maxwell Sehested, Peter B Jensen, Frank Gieseler, Pierre Rudolph

Lancet Oncol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myxoid cellular neurothekeoma.
Pierre Rudolph, Christoph Schubert

Am J Dermatopathol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Matthias Krams, Barbara Hero, Frank Berthold, Reza Parwaresch, Dieter Harms, Pierre Rudolph

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis